Retrograd intrarenal stenkirurgi. En metode til behandling af den ESWL-resistente nyresten - Retrograde intrarenal Stone Surgery

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2005-005972-34-DK

Enrollment

Registered

2006-01-05

Start date

2006-03-22

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

kidney stone

Interventions

Trade Name: Isoprenalin Product Name: isoprenalin Product Code: 5115 Pharmaceutical Form: Concentrate for solution for infusion Current Sponsor code: HJ1 Other descriptive name: isoprenalin Concentrat

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Stone surgery required Age > 18 years Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Previous coronary infarct Use of alpha-blocking or beta-blocking drugs Untreated hypertension Ureteral stone Malignant disase in the upper urinary tract Pregnancy

Design outcomes

Primary

Measure	Time frame
Main Objective: To lower the intrarenal pelvic pressure during retrograde intrarenal stone surgery by adding isoprenalin to the irrigation fluid during the operation.;Secondary Objective: To shorten surgical time in retrograde intrarenal stone surgery whilst optimizing security and quality of the procedure. To spare the kidney parenchyma from high pressures.;Primary end point(s): Lowering of the renal pelvic pressure. Making the procedure easier for the surgeon (=shorter duration of operation time, fewer complications)	—

Measure

Time frame

Main Objective: To lower the intrarenal pelvic pressure during retrograde intrarenal stone surgery by adding isoprenalin to the irrigation fluid during the operation.;Secondary Objective: To shorten surgical time in retrograde intrarenal stone surgery whilst optimizing security and quality of the procedure. To spare the kidney parenchyma from high pressures.;Primary end point(s): Lowering of the renal pelvic pressure. Making the procedure easier for the surgeon (=shorter duration of operation time, fewer complications)

—

Countries

Denmark

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026